Morgan Stanley
AKAO

Morgan Stanley’s Achaogen Inc AKAO Stock Holding History

Morgan Stanley’s Portfolio AKAO Stock Details AKAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-941,653
Closed -$430K – 6910
2019
Q1 		$430K Buy
941,653
+204,553
+28% +$215K ﹤0.01% 4632
2018
Q4 		$907K Buy
737,100
+492,791
+202% +$1.32M ﹤0.01% 4349
2018
Q3 		$974K Buy
244,309
+54,006
+28% +$326K ﹤0.01% 4562
2018
Q2 		$1.65M Buy
190,303
+12,281
+7% +$150K ﹤0.01% 4252
2018
Q1 		$2.31M Sell
178,022
-48,538
-21% -$551K ﹤0.01% 3866
2017
Q4 		$2.43M Buy
226,560
+43,959
+24% +$552K ﹤0.01% 3860
2017
Q3 		$2.91M Buy
182,601
+55,667
+44% +$1.06M ﹤0.01% 3518
2017
Q2 		$2.76M Buy
126,934
+83,236
+190% +$1.9M ﹤0.01% 3483
2017
Q1 		$1.1M Buy
43,698
+23,644
+118% +$486K ﹤0.01% 4309
2016
Q4 		$262K Sell
20,054
-23,446
-54% -$161K ﹤0.01% 5238
2016
Q3 		$208K Sell
43,500
-5,282
-11% -$21.1K ﹤0.01% 5004
2016
Q2 		$184K Buy
48,782
+3,052
+7% +$10.6K ﹤0.01% 4983
2016
Q1 		$126K Buy
45,730
+35,483
+346% +$138K ﹤0.01% 5207
2015
Q4 		$59K Buy
10,247
+3,629
+55% +$20.8K ﹤0.01% 5647
2015
Q3 		$38K Sell
6,618
-10,299
-61% -$70.2K ﹤0.01% 5836
2015
Q2 		$102K Sell
16,917
-9,584
-36% -$59.4K ﹤0.01% 5576
2015
Q1 		$259K Buy
26,501
+23,696
+845% +$267K ﹤0.01% 5068
2014
Q4 		$37K Sell
2,805
-1,500
-35% -$15.3K ﹤0.01% 5896
2014
Q3 		$39K Sell
4,305
-19,625
-82% -$201K ﹤0.01% 5808
2014
Q2 		$334K Buy
23,930
+23,696
+10,126% +$332K ﹤0.01% 4878
2014
Q1 		$4K Buy
+234
New +$4.05K ﹤0.01% 6282

Other funds holding AKAO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Morgan Stanley's AKAO Position: Q2 2019 in Review

Morgan Stanley sold out of Achaogen Inc (AKAO) in Q2 2019, closing a stake of 941,653 shares — an estimated $430K sold.

Morgan Stanley first reported a position in AKAO in Q1 2014 and held it in 21 quarters. The position peaked at $2.91M in Q3 2017. 8 funds tracked by Wall St. Rank hold AKAO as of Q2 2019.

  • Morgan Stanley reported no remaining Achaogen Inc position as of Q2 2019 after selling out during the quarter.
  • Morgan Stanley sold 941,653 Achaogen Inc shares in Q2 2019, an estimated $430K.
  • Morgan Stanley first reported a position in Achaogen Inc in Q1 2014 and held it in 21 quarters.
  • Morgan Stanley's Achaogen Inc position peaked at $2.91M in Q3 2017.
  • 8 funds tracked by Wall St. Rank held Achaogen Inc as of Q2 2019.

Based on Morgan Stanley's 13F filing for Q2 2019, filed 14 Aug 2019.